CARA is a multidisciplinary research institute with an emphasis on new inorganic materials and their applications, biosciences, and related technologies.
The center uses genome editing to accelerate the development of therapies for diseases that might otherwise never be treated, including rare genetic disorders.
At CCTD, the Innovative Genomics Institute and Apple Tree Partners accelerate treatment and prevention of human disease through interrogation and validation of drug targets.
The C3.ai Digital Transformation Institute research consortium accelerates the benefits of artificial intelligence for business, government, and society.
EBI provides access to world-class collaborative research facilities across the energy, chemical, material sciences, data sciences, engineering, and agriculture sectors.
LGR is UC Berkeley, UC San Francisco, and GlaxoSmithKline's state-of-the-art functional genomics laboratory for CRISPR technologies within the Innovative Genomics Institute.
